Home > Compliance Monitoring > Addiction Testing

AIT offers addiction testing for physicians managing dependency and detoxification

For individuals struggling with drug addiction, receiving professional help is often an important part of rehabilitation. Physicians who treat addiction work with patients to eliminate their dependence on narcotics and/or prescription drugs over time and to improve their quality of life. However, the road to recovery is long and difficult, and it is important to verify that your patients are only taking the prescribed medications designed to aid in this process.

AIT can help.

When it comes to prescription drug monitoring and narcotics testing, AIT was one of the first toxicology laboratories in the country to develop a testing program customized for healthcare providers monitoring patient compliance.

• Our cut-off levels are among the lowest in the industry
• We offer an addiction panel (link to PDF) that is custom designed for physicians treating dependency and detoxification
• Our sophisticated confirmation technology can provide a unique “chemical fingerprint” for any drug of interest
• Results can be available in as little as 48 hours, allowing for rapid assessment of results
• Full-time, expert toxicologists stand by ready to consult with you on interpretation of test results, drug interactions, and more

To learn more about our compliance testing services, click here. 

To read about our premiere prescription drug testing and narcotics panel, DetectiMed®, click here. 

Available Testing 

AIT’s compliance testing catalog includes numerous substances, including prescription and over-the-counter medications, illicit drugs, and other substances (as well as their metabolites). Of special interest to addictionologists is the availability of buprenorphine (Suboxone®) and methadone testing, which are frequently prescribed to recovering patients due to their ability to reduce the symptoms of opiate dependence and suppress symptoms of opioid withdrawal. While used to treat opioid dependence and as an analgesic alternative to other traditional opioids, these drugs still have abuse potential, and a patient can overdose if their usage is not monitored closely.

AIT has panels that can meet a variety of testing needs. In addition, you can begin testing from the moment of induction, allowing you to track the patient’s progress immediately upon beginning treatment at your facility.

To review the list of analytes in our DetectiMed Panel, click here. 

To access a condensed panel designed specifically for the addiction market, click here. 

For more information about AIT’s DetectiMed Panel and our prescription drug testing services, contact our Client Services Department.